Literature DB >> 34662161

Social Vulnerability and Premature Cardiovascular Mortality Among US Counties, 2014 to 2018.

Safi U Khan1, Zulqarnain Javed2, Ahmad N Lone3, Sourbha S Dani4, Zahir Amin5, Sadeer G Al-Kindi6, Salim S Virani7, Garima Sharma8, Ron Blankstein9, Michael J Blaha8, Miguel Cainzos-Achirica10,2, Khurram Nasir10,2,11.   

Abstract

BACKGROUND: Substantial differences exist between United States counties with regards to premature (<65 years of age) cardiovascular disease (CVD) mortality. Whether underlying social vulnerabilities of counties influence premature CVD mortality is uncertain.
METHODS: In this cross-sectional study (2014-2018), we linked county-level CDC/ATSDR SVI (Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry Social Vulnerability Index) data with county-level CDC WONDER (Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiological Research) mortality data. We calculated scores for overall SVI and its 4 subcomponents (ie, socioeconomic status; household composition and disability; minority status and language; and housing type and transportation) using 15 social attributes. Scores were presented as percentile rankings by county, further classified as quartiles on the basis of their distribution among all US counties (1st [least vulnerable] = 0 to 0.25; 4th [most vulnerable = 0.75 to 1.00]). We grouped age-adjusted mortality rates per 100 000 person-years for overall CVD and its subtypes (ischemic heart disease, stroke, hypertension, and heart failure) for nonelderly (<65 years of age) adults across SVI quartiles.
RESULTS: Overall, the age-adjusted CVD mortality rate per 100 000 person-years was 47.0 (ischemic heart disease, 28.3; stroke, 7.9; hypertension, 8.4; and heart failure, 2.4). The largest concentration of counties with more social vulnerabilities and CVD mortality were clustered across the southwestern and southeastern parts of the United States. The age-adjusted CVD mortality rates increased in a stepwise manner from 1st to 4th SVI quartiles. Counties in the 4th SVI quartile had significantly higher mortality for CVD (rate ratio, 1.84 [95% CI, 1.43-2.36]), ischemic heart disease (1.52 [1.09-2.13]), stroke (2.03 [1.12-3.70]), hypertension (2.71 [1.54-4.75]), and heart failure (3.38 [1.32-8.61]) than those in the 1st SVI quartile. The relative risks varied considerably by demographic characteristics. For example, among all ethnicities/races, non-Hispanic Black adults in the 4th SVI quartile versus the 1st SVI quartile exclusively had significantly higher relative risks of stroke (1.65 [1.07-2.54]) and heart failure (2.42 [1.29-4.55]) mortality. Rural counties with more social vulnerabilities had 2- to 5-fold higher mortality attributable to CVD and subtypes.
CONCLUSIONS: In this analysis, US counties with more social vulnerabilities had higher premature CVD mortality, varied by demographic characteristics and rurality. Focused public health interventions should address the socioeconomic disparities faced by underserved communities to curb the growing burden of premature CVD.

Entities:  

Keywords:  cardiovascular disease; cross-sectional studies; heart failure; mortality, premature; myocardial ischemia; public health

Mesh:

Year:  2021        PMID: 34662161     DOI: 10.1161/CIRCULATIONAHA.121.054516

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

1.  Social isolation and susceptibility for developing heart failure: are we exchanging a global pandemic for a new crisis in the making?

Authors:  Stefan Koudstaal
Journal:  Eur Heart J Open       Date:  2022-01-25

2.  Premature Cardiovascular Mortality in the United States: Who Will Protect the Most Vulnerable Among Us?

Authors:  Apoorva Gangavelli; Alanna A Morris
Journal:  Circulation       Date:  2021-10-18       Impact factor: 39.918

3.  Associations of Social Vulnerability Index With Pathologic Myocardial Findings at Autopsy.

Authors:  Ashwin Sunderraj; Adovich Rivera; Meghna Gaddam; Sarah Kim; Juan McCook; Janelle O'Neal; Jon Lomasney; Donald M Lloyd-Jones; Yvonne Baumer; Tiffany M Powell-Wiley; Matthew J Feinstein
Journal:  Front Cardiovasc Med       Date:  2021-12-23

4.  Injectable conductive gelatin methacrylate / oxidized dextran hydrogel encapsulating umbilical cord mesenchymal stem cells for myocardial infarction treatment.

Authors:  Shuoji Zhu; Changjiang Yu; Nanbo Liu; Mingyi Zhao; Zerui Chen; Jian Liu; Ge Li; Huanlei Huang; Huiming Guo; Tucheng Sun; Jimei Chen; Jian Zhuang; Ping Zhu
Journal:  Bioact Mater       Date:  2021-11-17

5.  Disproportionate Impact of COVID-19 Among Socially Vulnerable Patients.

Authors:  Safi U Khan; Kobina K Hagan; Zulqarnain Javed
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2022-07-18

6.  Identifying Differences: A Key Step in Precision Cardiovascular Disease Prevention.

Authors:  Mahmoud Al Rifai; Salim S Virani; Vijay Nambi
Journal:  J Am Heart Assoc       Date:  2022-07-25       Impact factor: 6.106

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.